Abonnement à la biblothèque: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publication de 6  numéros par an

ISSN Imprimer: 0743-4863

ISSN En ligne: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

RNA-Interference Effectors and Their Delivery

Volume 23, Numéro 2, 2006, pp. 137-164
DOI: 10.1615/CritRevTherDrugCarrierSyst.v23.i2.30
Get accessGet access

RÉSUMÉ

RNA-interference, the mechanism by which the expression of a specific protein can be reduced or eliminated, has emerged as a potential way to treat disease. RNA-interference effectors, such as small interfering RNA and small hairpin RNA, are double-stranded nucleic acid sequences expressly designed to have homology to sections of the target protein's mRNA, and when present in the cytosol trigger hydrolysis of the mRNA through the RNA-interference pathway. Because RNA-interference effectors are macromolecular and typically polyanionic, their efficacy is poor when not accompanied by a delivery vehicle. This review outlines the RNA-interference mechanism and discusses the delivery of RNA-interference effectors, with an emphasis on synthetic polymer-based delivery systems.

CITÉ PAR
  1. Transfection Technologies, in Handbook of Biochemistry and Molecular Biology, Fourth Edition, 2010. Crossref

  2. Salem Aliasger K., Behlke Mark A., SiRNA Delivery Vehicles, in RNA Interference, 2010. Crossref

  3. Ghonaim Hassan M., Li Shi, Blagbrough Ian S., Very Long Chain N 4 ,N 9 -Diacyl Spermines: Non-Viral Lipopolyamine Vectors for Efficient Plasmid DNA and siRNA Delivery, Pharmaceutical Research, 26, 1, 2009. Crossref

  4. Richardt-Pargmann Denise, Vollmer Jörg, Stimulation of the Immune System by Therapeutic Antisense Oligodeoxynucleotides and Small Interfering RNAs via Nucleic Acid Receptors, Annals of the New York Academy of Sciences, 1175, 1, 2009. Crossref

  5. Ghonaim Hassan M., Li Shi, Blagbrough Ian S., N 1,N 12 -Diacyl Spermines: SAR Studies on Non-viral Lipopolyamine Vectors for Plasmid DNA and siRNA Formulation, Pharmaceutical Research, 27, 1, 2010. Crossref

  6. De Laporte Laura, Shea Lonnie D., Matrices and scaffolds for DNA delivery in tissue engineering, Advanced Drug Delivery Reviews, 59, 4-5, 2007. Crossref

  7. de Martimprey H., Vauthier C., Malvy C., Couvreur P., Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA, European Journal of Pharmaceutics and Biopharmaceutics, 71, 3, 2009. Crossref

  8. Alshamsan Aws, Hamdy Samar, Samuel John, El-Kadi Ayman O.S., Lavasanifar Afsaneh, Uludağ Hasan, The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine, Biomaterials, 31, 6, 2010. Crossref

  9. Branco Monica C., Schneider Joel P., Self-assembling materials for therapeutic delivery, Acta Biomaterialia, 5, 3, 2009. Crossref

  10. Fischer J., Kolk A., Wolfart St., Pautke C., Warnke P.H., Plank C., Smeets R., Future of local bone regeneration – Protein versus gene therapy, Journal of Cranio-Maxillofacial Surgery, 39, 1, 2011. Crossref

  11. Zheng Xiaowen, Li Qian, Ma Lie, Gao Changyou, Skin Regeneration, in Polymeric Biomaterials for Tissue Regeneration, 2016. Crossref

  12. Clima L., Rotara A., Cojocaru C., Pinteala M., Simionescu B. C., Polymer engineering focusing on DRUG/GENE delivery and tissue engineering, 2015 E-Health and Bioengineering Conference (EHB), 2015. Crossref

  13. Oku Naoto, Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases, Biological & Pharmaceutical Bulletin, 40, 2, 2017. Crossref

  14. Ashrafizadeh Milad, Ahmadi Zahra, Kotla Niranjan G., Afshar Elham Ghasemipour, Samarghandian Saeed, Mandegary Ali, Pardakhty Abbas, Mohammadinejad Reza, Sethi Gautam, Nanoparticles Targeting STATs in Cancer Therapy, Cells, 8, 10, 2019. Crossref

  15. Blagbrough Ian S., Metwally Abdelkader A., Ghonaim Hassan M., Asymmetrical N4,N9-Diacyl Spermines: SAR Studies of Nonviral Lipopolyamine Vectors for Efficient siRNA Delivery with Silencing of EGFP Reporter Gene, Molecular Pharmaceutics, 9, 7, 2012. Crossref

  16. Alshamsan Aws, Haddadi Azita, Incani Vanessa, Samuel John, Lavasanifar Afsaneh, Uludağ Hasan, Formulation and Delivery of siRNA by Oleic Acid and Stearic Acid Modified Polyethylenimine, Molecular Pharmaceutics, 6, 1, 2009. Crossref

  17. Saad Maha, Garbuzenko Olga B, Minko Tamara, Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer, Nanomedicine, 3, 6, 2008. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain